Stephen L Sabba insider trades

Open-market stock purchases and sales by Stephen L Sabba, Director at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since May 29, 2009.

Recent trades

DateStockTradeValue
Jun 16, 2026LGND Ligand Pharmaceuticals IncSold$545K
Jun 16, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Mar 23, 2026LGND Ligand Pharmaceuticals IncSold$208K
Mar 3, 2026LGND Ligand Pharmaceuticals IncSold$410K
Mar 3, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 3 buys, 12 sales, last Jun 16, 2026
  • NVLN Novelion Therapeutics Inc: other filings, last Aug 9, 2018
  • QLTI QLT Inc/bc: other filings, last Jun 17, 2016
  • QLT QLT Inc/bc: other filings, last Jul 10, 2012

Get free alerts when Stephen L Sabba files a new trade →